Publication Date
4-1-2022
Journal
Expert Opinion on Therapeutic Targets
DOI
10.1080/14728222.2022.2067479
PMID
35426759
PMCID
PMC9081256
PubMedCentral® Posted Date
4-25-2023
PubMedCentral® Full Text Version
Author MSS
Published Open-Access
yes
Keywords
Calcium, Calcium Signaling, Heart Diseases, Humans, Myocytes, Cardiac, Ryanodine Receptor Calcium Release Channel, Sarcoplasmic Reticulum
Abstract
INTRODUCTION: Abnormal calcium signaling between organelles such as the sarcoplasmic reticulum (SR), mitochondria and lysosomes is a key feature of heart diseases. Calcium serves as a secondary messenger mediating inter-organellar crosstalk, essential for maintaining the cardiomyocyte function.
AREAS COVERED: This article examines the available literature related to calcium channels and transporters involved in inter-organellar calcium signaling. The SR calcium-release channels ryanodine receptor type-2 (RyR2) and inositol 1,4,5-trisphosphate receptor (IP
EXPERT OPINION: Enhanced SR calcium release via RyR2 and reduced SR reuptake via SERCA2a, increased VDAC and MCUC-mediated calcium uptake into mitochondria, and enhanced lysosomal calcium-release via lysosomal TPC and TRPML may all contribute to aberrant calcium homeostasis causing heart disease. While mechanisms of this crosstalk need to be studied further, interventions targeting these calcium channels or combinations thereof might represent a promising therapeutic strategy.
Included in
Biochemistry, Biophysics, and Structural Biology Commons, Biology Commons, Cardiovascular Diseases Commons, Medical Sciences Commons, Medical Specialties Commons